Matsumoto, Kazuko <br/><br/>
Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.  [electronic resource] 

 -  Journal of proteome research  Feb 2009 
 - 457-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-3893 
<br/><br/><label>Standard No.: </label>10.1021/pr800655p  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--metabolism<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--metabolism<br/>Biomarkers--blood<br/>Breast Neoplasms--drug therapy<br/>Carbohydrate Conformation<br/>Carbohydrate Sequence<br/>Disease-Free Survival<br/>Female<br/>Fucosyltransferases--metabolism<br/>Humans<br/>Middle Aged<br/>Molecular Sequence Data<br/>Polysaccharides--chemistry<br/>Prospective Studies<br/>Receptor, ErbB-2--genetics<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization--methods<br/>Trastuzumab<br/>Treatment Outcome<br/>alpha-L-Fucosidase--blood